Tag Archives: Thom Tillis

This Is What Orrin Hatch Told the Senate About Medical Cannabis Research

This Is What Orrin Hatch Told the Senate About Medical Cannabis Research

This Is What Orrin Hatch Told the Senate About Medical Cannabis Research

On Sept. 13, 2017, U.S. Sen. Orrin Hatch, R-Utah, introduced legislation to cut the bureaucratic red tape thwarting medical cannabis research so health care professionals can harness the medicinal properties of the plant to reduce the suffering of patients in need.

Tillis Co-Introduces Bipartisan Legislation To Expand Research Into Medical Value Of Marijuana

WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Thom Tillis (R-NC) joined Senators Brian Schatz (D-HI), Orrin Hatch (R-UT), Cory Gardner (R-CO) and Chris Coons (D-DE) to introduce the Marijuana Effective Drug Studies (MEDS) Act of 2017, bipartisan legislation that would make it easier for researchers to study the medical effectiveness and safety of marijuana.

Hatch Introduces Medical Marijuana Research Bill

WASHINGTON, Sept. 13, 2017 /Weed Wire/ — Today, Senator Orrin Hatch (R-UT) introduced the Marijuana Effective Drug Study Act of 2017, or MEDS Act, to improve the process for conducting scientific research on marijuana as a safe and effective medical treatment. In introducing this legislation, Senator Hatch was joined by Senator Schatz (D-HI) and cosponsors Senator Chris Coons (D-DE), Senator Cory Gardner (R-CO), and Senator Thom Tillis (R-NC).

Tillis Co-Sponsors Legislation to Expand Research into Medical Benefits of Cannabidiol

RALEIGH, N.C., June 5, 2017 /Weed Wire/ – U.S. Senator Thom Tillis (R-NC) recently co-sponsored the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.

Federal Legislation: Cannabidiol Research Expansion Act Introduced

Federal Legislation: Cannabidiol Research Expansion Act Introduced

On May 25, 2017, Sens. Dianne Feinstein, D-Calif., and Chuck Grassley, R-Iowa, announced that they had introduced the Cannabidiol Research Expansion Act, a bill that would ask the Attorney General to reconsider whether cannabidiol should be scheduled under the Controlled Substances Act and expand research opportunities as a means of determining the medical efficacy of cannabidiol and marijuana in the treatment of serious medical conditions.

Feinstein, Grassley Introduce Bill to Expand Research into Medical Benefits of Cannabidiol and Marijuana

WASHINGTON, May 25, 2017 /Weed Wire/ — Senators Dianne Feinstein (D-Calif.) and Chuck Grassley (R-Iowa), leaders of the Senate Caucus on International Narcotics Control, today introduced the Cannabidiol Research Expansion Act, a bill to support research initiatives on the potential benefits of substances such as cannabidiol (CBD) that are derived from marijuana.


Top